SCHEMBL22904124

SCHEMBL22904124

O=C1CC2(Nc3ccccc3C2=O)C(=O)N1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.38
ALDH1A1 P00352 6/20 0.38
HSD17B10 Q99714 1/20 0.38
HPGD P15428 3/20 0.36
MAPT P10636 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
CACNA1B Q00975 1/20 0.36
APBA1 Q02410 1/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
PDGFRA P16234 1/20 0.36
FER P16591 1/20 0.36
LTK P29376 1/20 0.36
CDK8 P49336 1/20 0.36
ACVR1 Q04771 1/20 0.36
LRRK2 Q5S007 1/20 0.36
DYRK1B Q9Y463 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8728316 0.72 ALDH1A1 (0.45) KDM4EALDH1A1HSD17B10MAPTTDP2
SCHEMBL11534081 0.71 ALDH1A1 (0.39) KDM4EALDH1A1HSD17B10HPGDMAOA
SCHEMBL11536434 0.68 MAOA (0.47) KDM4EALDH1A1HSD17B10HPGDMAOA
SCHEMBL10606625 0.68 AKR1B1 (0.57)
SCHEMBL13469502 0.66 ALDH1A1 (0.52) KDM4EALDH1A1HSD17B10HPGDCYP3A4
SCHEMBL16163017 0.66 PDE7A (0.54) KDM4EALDH1A1HSD17B10HPGDMAOA
SCHEMBL29244276 0.63 MAOA (0.38) KDM4EALDH1A1HSD17B10HPGDMAPT
SCHEMBL29604423 0.63 MAOA (0.41) KDM4EALDH1A1HSD17B10HPGDMAOA
SCHEMBL1789178 0.63 MAOA (0.41) KDM4EALDH1A1HSD17B10HPGDMAOA
SCHEMBL16163323 0.63 ITGA4 (0.53) KDM4EALDH1A1HSD17B10MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021011631-A1 FUSED-GLUTARIMIDE CRBN LIGANDS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2021-01-21 WO disclosed